BRAINSWAY LTD-ADR (BWAY) Fundamental Analysis & Valuation

NASDAQ:BWAY • US10501L1061

Current stock price

12.3 USD
-0.28 (-2.23%)
Last:

This BWAY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. BWAY Profitability Analysis

1.1 Basic Checks

  • BWAY had positive earnings in the past year.
  • BWAY had a positive operating cash flow in the past year.
  • In the past 5 years BWAY reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: BWAY reported negative operating cash flow in multiple years.
BWAY Yearly Net Income VS EBIT VS OCF VS FCFBWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • BWAY's Return On Assets of 5.53% is amongst the best of the industry. BWAY outperforms 81.38% of its industry peers.
  • BWAY's Return On Equity of 8.92% is amongst the best of the industry. BWAY outperforms 80.85% of its industry peers.
  • BWAY's Return On Invested Capital of 2.75% is fine compared to the rest of the industry. BWAY outperforms 70.21% of its industry peers.
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROIC 2.75%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
BWAY Yearly ROA, ROE, ROICBWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • Looking at the Profit Margin, with a value of 12.73%, BWAY belongs to the top of the industry, outperforming 86.70% of the companies in the same industry.
  • The Operating Margin of BWAY (5.78%) is better than 71.28% of its industry peers.
  • BWAY's Gross Margin of 74.92% is amongst the best of the industry. BWAY outperforms 85.11% of its industry peers.
  • BWAY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
BWAY Yearly Profit, Operating, Gross MarginsBWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BWAY Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BWAY is destroying value.
  • There is no outstanding debt for BWAY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BWAY Yearly Shares OutstandingBWAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BWAY Yearly Total Debt VS Total AssetsBWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • An Altman-Z score of 3.47 indicates that BWAY is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.47, BWAY is in the better half of the industry, outperforming 70.21% of the companies in the same industry.
  • BWAY has a debt to FCF ratio of 0.37. This is a very positive value and a sign of high solvency as it would only need 0.37 years to pay back of all of its debts.
  • BWAY has a Debt to FCF ratio of 0.37. This is amongst the best in the industry. BWAY outperforms 92.02% of its industry peers.
  • A Debt/Equity ratio of 0.08 indicates that BWAY is not too dependend on debt financing.
  • BWAY's Debt to Equity ratio of 0.08 is fine compared to the rest of the industry. BWAY outperforms 67.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Altman-Z 3.47
ROIC/WACC0.32
WACC8.47%
BWAY Yearly LT Debt VS Equity VS FCFBWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • BWAY has a Current Ratio of 3.19. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.19, BWAY is in line with its industry, outperforming 56.38% of the companies in the same industry.
  • A Quick Ratio of 3.02 indicates that BWAY has no problem at all paying its short term obligations.
  • The Quick ratio of BWAY (3.02) is better than 64.36% of its industry peers.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 3.02
BWAY Yearly Current Assets VS Current LiabilitesBWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BWAY Growth Analysis

3.1 Past

  • BWAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 117.91%, which is quite impressive.
EPS 1Y (TTM)117.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.8%

3.2 Future

  • BWAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.61% yearly.
  • BWAY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.69% yearly.
EPS Next Y-3.28%
EPS Next 2Y29.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25.98%
Revenue Next 2Y26.09%
Revenue Next 3Y23.69%
Revenue Next 5YN/A

3.3 Evolution

BWAY Yearly Revenue VS EstimatesBWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
BWAY Yearly EPS VS EstimatesBWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2

More info and screens

Find the best growth stocksShow best growing peers

7

4. BWAY Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.53, the valuation of BWAY can be described as reasonable.
  • Based on the Price/Earnings ratio, BWAY is valued cheaper than 92.55% of the companies in the same industry.
  • BWAY's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.21.
  • With a Price/Forward Earnings ratio of 9.88, the valuation of BWAY can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, BWAY is valued cheaply inside the industry as 93.62% of the companies are valued more expensively.
  • BWAY is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.53
Fwd PE 9.88
BWAY Price Earnings VS Forward Price EarningsBWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 67.55% of the companies in the same industry are more expensive than BWAY, based on the Enterprise Value to EBITDA ratio.
  • 96.28% of the companies in the same industry are more expensive than BWAY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.15
EV/EBITDA 38.22
BWAY Per share dataBWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as BWAY's earnings are expected to grow with 29.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.61%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BWAY Dividend Analysis

5.1 Amount

  • No dividends for BWAY!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BWAY Fundamentals: All Metrics, Ratios and Statistics

BRAINSWAY LTD-ADR

NASDAQ:BWAY (4/7/2026, 11:23:31 AM)

12.3

-0.28 (-2.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-11
Earnings (Next)05-11
Inst Owners5.36%
Inst Owner Change0%
Ins Owners15.48%
Ins Owner Change0%
Market Cap241.22M
Revenue(TTM)N/A
Net Income(TTM)6.25M
Analysts85.71
Price TargetN/A
Short Float %N/A
Short Ratio0.87
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.34%
Min EPS beat(2)35.56%
Max EPS beat(2)95.12%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-22.64%
Max EPS beat(4)95.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-1.07%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-11.32%
Revenue beat(16)6
Avg Revenue beat(16)-26.49%
PT rev (1m)0%
PT rev (3m)-0.49%
EPS NQ rev (1m)-0.02%
EPS NQ rev (3m)-0.26%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)5.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.87%
Valuation
Industry RankSector Rank
PE 9.53
Fwd PE 9.88
P/S 4.91
P/FCF 13.15
P/OCF 10.83
P/B 3.44
P/tB 3.44
EV/EBITDA 38.22
EPS(TTM)1.29
EY10.49%
EPS(NY)1.25
Fwd EY10.12%
FCF(TTM)0.94
FCFY7.6%
OCF(TTM)1.14
OCFY9.23%
SpS2.5
BVpS3.57
TBVpS3.57
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.18
Profitability
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROCE 3.26%
ROIC 2.75%
ROICexc 15.43%
ROICexgc 15.43%
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
FCFM 37.36%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Debt/EBITDA 1.21
Cap/Depr 207.6%
Cap/Sales 8.01%
Interest Coverage 26.28
Cash Conversion 470.69%
Profit Quality 293.55%
Current Ratio 3.19
Quick Ratio 3.02
Altman-Z 3.47
F-Score5
WACC8.47%
ROIC/WACC0.32
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.68%
EPS Next Y-3.28%
EPS Next 2Y29.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.8%
Revenue Next Year25.98%
Revenue Next 2Y26.09%
Revenue Next 3Y23.69%
Revenue Next 5YN/A
EBIT growth 1Y147.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.54%
EBIT Next 3Y43.13%
EBIT Next 5YN/A
FCF growth 1Y441.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y749.36%
OCF growth 3Y127.03%
OCF growth 5YN/A

BRAINSWAY LTD-ADR / BWAY Fundamental Analysis FAQ

What is the fundamental rating for BWAY stock?

ChartMill assigns a fundamental rating of 5 / 10 to BWAY.


Can you provide the valuation status for BRAINSWAY LTD-ADR?

ChartMill assigns a valuation rating of 7 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.


Can you provide the profitability details for BRAINSWAY LTD-ADR?

BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.


How financially healthy is BRAINSWAY LTD-ADR?

The financial health rating of BRAINSWAY LTD-ADR (BWAY) is 7 / 10.